Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pain Therapeutics (PTIE)

Pain Therapeutics (PTIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pain Therapeutics 7801 NORTH CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 USA

www.paintrials.com P: 512-501-2444

Description:

Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.

Key Statistics

Overview:

Market Capitalization, $K 21,352
Shares Outstanding, K 17,219
Annual Sales, $ 0 K
Annual Net Income, $ -11,910 K
60-Month Beta 1.91
% of Insider Shareholders 31.40%
% of Institutional Shareholders 17.40%
Float, K 11,812
% Float 68.60%

Growth:

1-Year Return -80.98%
3-Year Return -91.98%
5-Year Return -96.75%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -225.00%
5-Year Dividend Growth -100.00%

Per-Share Information:

Next Earnings Date 05/08/19
Earnings Per Share ttm -0.80
EPS Growth vs. Prev Qtr 63.64%
EPS Growth vs. Prev Year 89.19%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.750 on 12/13/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 05/10/17

PTIE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.68%
Return-on-Assets % -47.15%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.07
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar